1. Anti‐inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. (1st May 2018) Authors: Wu, J.J.; Joshi, A.A.; Reddy, S.P.; Batech, M.; Egeberg, A.; Ahlehoff, O.; Mehta, N.N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 8(2018) Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗